Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The inauguration of a new joint Shoklo Malaria Research Unit (SMRU) and Borderland Health Foundation (BHF) Building took place in Mae Ramat, Thailand, this week.

© SMRU/Borderland Health Foundation (BHF)

This joint venture was funded by the Wellcome Trust and the Nuffield Department of Medicine and will provide quality health care to the marginalized populations living on both sides of the Thai-Myanmar border in the Mae Sot area, and Tak Province. SMRU delivers this through a unique combination of research and humanitarian services, with an emphasis on maternal-child health and infectious diseases.

The ceremony commenced with speeches by the deputy chief of the Tak Provincial Health Authority; Prof Chris Conlon, Head of NDM's Centre for Tropical Medicine and Global Health; Dr Julia Kemp from the Wellcome Trust; and Dr Supakit Sirilak, Deputy Permanent Secretary, Thai Ministry of Public Health. The building was then formally opened in a ribbon-cutting ceremony by Dr Supakit, Dr Kemp, Prof Gavin Screaton, Head of the Medical Sciences Division, and Prof François Nosten, the founding Director of both SMRU and BHF.

Amongst the delegates were Dr Suta  Pattarakijroongrueng, Director Mae Ra Mart Hospital; Mr Boonliem  Takham, Mae Ra Mart District Administration; Ms Amornrat Tatsanakit, Director Regional Medical Science Center 2 Phitsanulok, Dr Wittaya  Polseela and Dr Purichat Yingrangsan from Tak PHO, as well as representatives from local hospitals, community-based organisations and NGOs and the construction company.

SMRU provides logistical support and has laboratory facilities including a malaria lab, haematology lab, insectary, microbiology lab and freezer room. It provides community engagement, maternal and child health, malaria elimination task force and a tuberculosis programme to the over 130,000 Karen, Mon, Karenni ethnic minority groups living in a string of refugee camps along the Thai-Myanmar border.

Similar stories

Three NDM researchers awarded Associate Professorships

We are delighted to announce that three researchers have been awarded the Associate Professor title, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.

Oxford’s RECOVERY trial team amongst MRC‘s Outstanding Team Impact prize finalists

The inaugural MRC Impact Prize recognises teams who have made outstanding impacts in health and medical research. The winners will be announced at a ceremony in the spring.

Research partnership with the University of Navarra agreed

The Nuffield Department of Medicine and the University of Navarra have entered into a Memorandum of Understanding for collaboration on research and to apply new immunotherapy techniques to cancer patients.

Prof James Naismith elected as Academy of Medical Sciences' Vice President

Established in 1998, the Academy of Medical Sciences is one of the four UK National Academies, coordinating scholarly research activities and standards in the UK.

NDM contributes to new UK research consortium to tackle monkeypox outbreak

The UK’s efforts to tackle the monkeypox outbreak will receive a huge boost with the creation of a new research consortium working together to develop better diagnostic tests, identify potential therapies and study vaccine effectiveness.

Online postgraduate diploma to tackle inequities in health research leadership

Accepting its first students in in October 2023, the Postgraduate Diploma in Global Health Research is specifically targeted at researchers and clinicians in low income countries, and will offer accessibility never previously available.